Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK6640 Phase I single-dose study in Alzheimer's disease
jRCT2080222766Phase 1
- Sponsor
- Kyowa Kirin
- Start
- Feb 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Peptides
- Countries
- 1
01
Overview
Phase 1, single-arm trial of KHK6640 in Alzheimer's disease (AD), sponsored by Kyowa Kirin.
02
Drugs
KHK6640
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080222766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222766.